US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalR
RGEN
Repligen
142.44
-2.93-2.02%Pre Market: 143.14 +0.70 +0.49%07:09 03/14 EDT
OPEN/PREV CLOSE145.18/145.37
TODAY RANGE140.93-146.65
VOL803
MARKET CAP7.98B
52 WEEK RANGE113.50-200.23
AVG VOL (3M)618.80K
% TURNOVER0.83%
TURNOVER0
P/E (TTM)-312.2999
% RANGE3.93%
EPS(TTM)-0.4561
P/E(FORWARD)83.37
P/B3.957
BVPS36.00
DIVIDEND--
P/S12.44
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.55B
SHARES OUTSTANDING56.03M
NEXT EARNINGS04/29-05/05
FREE FLOAT53.03M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·03/04 18:26
908 Devices Strategic Shift: Desktop Sale To Repligen Optimizes Future Growth
TipRanks·03/04 18:01
Repligen deal can expand bioprocessing opportunities, says RBC Capital
TipRanks·03/04 13:47
Craig-Hallum Remains a Buy on Repligen (RGEN)
Seeking Alpha·03/04 13:46
908 Devices jumps as Repligen buys bioprocessing analytics portfolio
Dow Jones·03/04 12:55
Repligen Buys 908 Devices Bioprocessing Analytics Portfolio for $70 Million
TipRanks·03/04 12:42
Repligen acquires bioprocessing analytic portfolio from 908 Devices for $70M
Reuters·03/04 12:32
REPLIGEN CORP: PURCHASE CONSIDERATION IS A PAYMENT OF $70 MLN IN CASH
Dow Jones·03/04 12:32
*908 Devices: Purchase Consideration Is Payment of $70M in Cash >MASS
Dow Jones·03/04 12:30
*Repligen Purchases Bioprocessing Analytics Portfolio From 908 Devices for $70M
TipRanks·03/03 22:19
Repligen Delays 2024 Yearly Report Filing
Same Industry
Name/Symbol
Change%
Price